A pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of AGRANULOCYTOSIS. A breath test with 13C-labeled aminopyrine has been used as a non-invasive measure of CYTOCHROME P-450 metabolic activity in LIVER FUNCTION TESTS.
Aminopyrine N-Demethylase is an enzyme, specifically a cytochrome P450 isoform, involved in the metabolism of drugs and xenobiotics, responsible for catalyzing the N-demethylation reaction.
An NADPH-dependent P450 enzyme that plays an essential role in the sterol biosynthetic pathway by catalyzing the demethylation of 14-methyl sterols such as lanosterol. The enzyme acts via the repeated hydroxylation of the 14-methyl group, resulting in its stepwise conversion into an alcohol, an aldehyde and then a carboxylate, which is removed as formic acid. Sterol 14-demethylase is an unusual cytochrome P450 enzyme in that it is found in a broad variety of organisms including ANIMALS; PLANTS; FUNGI; and protozoa.
Enzymes that catalyse the removal of methyl groups from LYSINE or ARGININE residues found on HISTONES. Many histone demethylases generally function through an oxidoreductive mechanism.
A family of histone demethylases that share a conserved Jumonji C domain. The enzymes function via an iron-dependent dioxygenase mechanism that couples the conversion of 2-oxoglutarate to succinate to the hydroxylation of N-methyl groups.
Oxidoreductases, N-Demethylating are enzymes that catalyze the oxidation of N-methyl groups to carbonyl groups, typically found in xenobiotic metabolism, involving the removal of methyl groups from various substrates using molecular oxygen.
A drug-metabolizing, cytochrome P-450 enzyme which catalyzes the hydroxylation of aniline to hydroxyaniline in the presence of reduced flavoprotein and molecular oxygen. EC 1.14.14.-.
Rounded or pyramidal cells of the GASTRIC GLANDS. They secrete HYDROCHLORIC ACID and produce gastric intrinsic factor, a glycoprotein that binds VITAMIN B12.
Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough.
A retinoblastoma binding protein that is also a member of the Jumonji-domain histone demethylases. It has demethylation activity towards specific LYSINE residues found on HISTONE H3.
A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism.
Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed)
Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each.
Hydrochloric acid present in GASTRIC JUICE.
Oxidative enzyme which transforms p-nitroanisole into p-nitrophenol.
Drug metabolizing enzymes which oxidize methyl ethers. Usually found in liver microsomes.
An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
A drug that has analgesic, anti-inflammatory, and antipyretic properties. It is the sodium sulfonate of AMINOPYRINE.
An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.
The removing of alkyl groups from a compound. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)
A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
A barbiturate that is effective as a hypnotic and sedative.
A group of compounds that contain a bivalent O-O group, i.e., the oxygen atoms are univalent. They can either be inorganic or organic in nature. Such compounds release atomic (nascent) oxygen readily. Thus they are strong oxidizing agents and fire hazards when in contact with combustible materials, especially under high-temperature conditions. The chief industrial uses of peroxides are as oxidizing agents, bleaching agents, and initiators of polymerization. (From Hawley's Condensed Chemical Dictionary, 11th ed)
Compounds with a five-membered heterocyclic ring with two nitrogens and a keto OXYGEN. Some are inhibitors of TNF-ALPHA production.
A triterpene that derives from the chair-boat-chair-boat folding of 2,3-oxidosqualene. It is metabolized to CHOLESTEROL and CUCURBITACINS.
A barbiturate that is used as a sedative. Secobarbital is reported to have no anti-anxiety activity.
A flavoprotein that catalyzes the reduction of heme-thiolate-dependent monooxygenases and is part of the microsomal hydroxylating system. EC 1.6.2.4.
A hypnotic and sedative. Its use has been largely superseded by other drugs.
A saclike, glandular diverticulum on each ductus deferens in male vertebrates. It is united with the excretory duct and serves for temporary storage of semen. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed)
An enzyme that catalyzes the methylation of the epsilon-amino group of lysine residues in proteins to yield epsilon mono-, di-, and trimethyllysine. EC 2.1.1.43.
Widely distributed enzymes that carry out oxidation-reduction reactions in which one atom of the oxygen molecule is incorporated into the organic substrate; the other oxygen atom is reduced and combined with hydrogen ions to form water. They are also known as monooxygenases or hydroxylases. These reactions require two substrates as reductants for each of the two oxygen atoms. There are different classes of monooxygenases depending on the type of hydrogen-providing cosubstrate (COENZYMES) required in the mixed-function oxidation.
An essential amino acid. It is often added to animal feed.
Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones.
Any tests done on exhaled air.
A genetic process by which the adult organism is realized via mechanisms that lead to the restriction in the possible fates of cells, eventually leading to their differentiated state. Mechanisms involved cause heritable changes to cells without changes to DNA sequence such as DNA METHYLATION; HISTONE modification; DNA REPLICATION TIMING; NUCLEOSOME positioning; and heterochromatization which result in selective gene expression or repression.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.
Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding.
Aniline compounds, also known as aromatic amines, are organic chemicals derived from aniline (aminobenzene), characterized by the substitution of hydrogen atoms in the benzene ring with amino groups (-NH2).
Semicarbazides are organic compounds containing a functional group with the structure NH2-NH-CO-NH2, which are commonly used as reagents in chemical reactions to form semicarbazones, and can also be found in some pharmaceuticals and industrial chemicals.
A flavoring agent. It is the intermediate product in the two-step bioconversion of ferulic acid to vanillin. (J Biotechnol 1996;50(2-3):107-13).
A family of proteins that share the F-BOX MOTIF and are involved in protein-protein interactions. They play an important role in process of protein ubiquition by associating with a variety of substrates and then associating into SCF UBIQUITIN LIGASE complexes. They are held in the ubiquitin-ligase complex via binding to SKP DOMAIN PROTEINS.
A sympathomimetic agent with properties similar to DEXTROAMPHETAMINE. It is used in the treatment of obesity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1222)
A carcinogen that is often used in experimental cancer studies.
Cytochrome reductases are enzymes that catalyze the transfer of electrons from donor molecules to cytochromes in electron transport chains, playing a crucial role in cellular respiration and energy production within cells.
The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9)
An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis.
Five membered rings containing a NITROGEN atom.
A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. (From AMA Drug Evaluations Annual, 1994, p311)
Sulfur compounds in which the sulfur atom is attached to three organic radicals and an electronegative element or radical.
A megaloblastic anemia occurring in children but more commonly in later life, characterized by histamine-fast achlorhydria, in which the laboratory and clinical manifestations are based on malabsorption of vitamin B 12 due to a failure of the gastric mucosa to secrete adequate and potent intrinsic factor. (Dorland, 27th ed)
Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension.

Role of C-5 chiral center in R-(+)-pulegone-mediated hepatotoxicity: metabolic disposition and toxicity of 5, 5-dimethyl-2-(1-Methylethylidene)-cyclohexanone in rats. (1/55)

Metabolic disposition of 5, 5-dimethyl-2-(1-methylethylidene)-cyclohexanone (I) was examined in rats. Compound (I) was administered orally (250 mg/kg of body weight/day) to rats for 5 days. The following urinary metabolites were isolated and identified: 4,5,6,7-tetrahydro-3,6, 6-trimethylbenzofuran (III), 3,3-dimethylcyclohexanone (VI), 5, 5-dimethyl-3-hydroxy-2-(1-methylethylidene)-cyclohexanone (X), 5, 5-dimethyl-2-(1-hydroxymethylethyl)-cyclohexanone (IX), 3-hydroxy-5-hydroxymethyl-5-methyl-2-(1-methylethylidene)-cyclo hexano ne (XI), 5,6-dihydro-3,6,6-trimethyl-2(4H)-benzofuranone (VIII), and 5,5-dimethyl-3-hydroxy-2-(1-carboxy ethylidene)-cyclohexanone (XIII). Incubation of compound (I) with phenobarbital (PB)-induced rat liver microsomes in the presence of NADPH resulted in the formation of a metabolite, tentatively identified as a furanoterpene (III) based on proton magnetic resonance, gas chromatography, and gas chromatography-mass spectroscopy analyses. The formation of III was inhibited to a significant extent by carbon monoxide, metyrapone, SKF 525-A, and cytochrome c, suggesting the participation of PB-induced microsomal cytochrome P-450 system in the conversion of I to III. Compound I gave type I spectral change in the PB-induced liver microsomes and the dissociation constant (Ks) for I was 38.5 microM. Intraperitoneal administration of a single dose (250 mg/kg) of I to rats resulted in 26, 23, and 41% decreases in the levels of cytochrome P-450, glucose-6-phosphatase, and aminopyrine N-demethylase, respectively, at the end of 24 h. During this period, a 11-fold increase in serum glutamate pyruvate transaminase level was also observed. However, a decrease in the level of cytochrome P-450 and glucose-6-phosphatase, and an increase in serum glutamate pyruvate transaminase values were comparatively more pronounced when R-(+)-pulegone (250 mg/kg) or CCl(4) (0.6 ml/kg) was administered to rats. Pretreatment of rats with PB potentiated the hepatotoxicity caused by I, whereas pretreatment with 3-methylcholanthrene protected from it. This suggests that PB-induced cytochrome P-450-catalyzed reactive metabolites may be responsible for the toxic effects caused by I.  (+info)

Studies on the formation of lipid peroxides and on some enzymic activities in the liver of vitamin E-deficient rats. (2/55)

Rats were fed a 5 or 20% casein diet that causes liver necrosis unless supplemented with vitamin E or selenite. The following activities were studied in liver subcellar fractions: enzymic formation of lipid peroxides, NADPH-cytochrome c reductase, oxidative demethylation of aminopyrine, and incorporation of [14C]leucine into protein (with microsomes); xanthine oxidase (with soluble supernatant); and RNA polymerases I and II (with nuclei). Formation of lipid peroxides was higher in rats fed diets without vitamin E and was not reduced significantly by dietary selenite. The activity of xanthine oxidase was higher in animals fed the 20% casein than in those fed the 5% casein diet; however, a higher activity was observed in the rats fed the latter diet without vitamin E or selenite than in those receiving these supplements. The activity of RNA polymerase I was higher in rats fed the low casein diet. Other activities examined were not affected significantly by the level of dietary casein or by vitamin E or selenits.  (+info)

Effect of repeated exposure to aniline, nitrobenzene, and benzene on liver microsomal metabolism in the rat. (3/55)

Exposure of rats to aniline at daily doses of 50 mg/kg of body weight over a month stimulated the microsomal metabolism as manifested by (1) acceleration of p-hydroxylation of anilin and N-demethylation of aminopyrine in 9-000 times g postmitochondrial supernatant of the liver, (2) shortening the sleeping time after hexobarbital, and (3) reduction of the antipyretic effect of phenacetin. In the rats exposed to nitrobenzene in a similar manner to aniline, nitroreduction of nitrobenzene and p-hydroxylation of aniline remained unaffected; the antipyretic effect of phenacetin was decreased, whereas hexobarbital sleeping time remained unchanged. Exposure of rats to benzene (50 mg/kg of body weight daily for a month) had no effect on the rate of hydroxylation of benzene and N-demethylation of aminopyrine. In benzene-exposed rats hexobarbital sleeping time was prolonged whereas the antipyretic effect of phenacetin was unaffected. Microsomal metabolism of aniline, nitrobenzene, and benzene was stimulated and inhibited when the rats were pretreated with phenobarbital and SKF 525-A, respectively.  (+info)

Induction of drug metabolism-related enzymes by methylcholanthrene and phenobarbital in transgenic mice carrying human prototype c-Ha-ras gene and their wild type littermates. (4/55)

Transgenic mice hemizygously carrying human c-Ha-ras proto-oncogene, Tg-rasH2 show very sensitive and facilitated carcinogenicity to various carcinogens. In this study, activities of certain enzymes related to drug metabolism and energy metabolism were measured in microsome and cytosol fractions of livers of Tg-rasH2 mice and their wild type littermates with both sexes treated with 3-methylcholanthrene (MC) and phenobarbital (PB). Aminopyrine N-demethylase activities increased significantly in livers of all mice treated with PB. MC and PB treatments induced significant increases in activities of UDP-glucuronosyltransferase and S-adenosyl homocysteinase compared to those in the non-treated groups in microsome fractions from all mice. In cytosol fractions of livers of all mice, glutathione S-transferase activity was significantly induced in the PB treated groups. There were no significant differences in activities of lactate dehydrogenase, glucose 6-phosphate dehydrogenase, pyruvate kinase and glucose 6-phosphatase related to energy metabolism in livers and kidneys among all mice. Tg-rasH2 mice showed stable activities of enzymes related to drug detoxication and energy metabolism similar to those of non-transgenic mice. These results suggest that the human c-Ha-ras transgene may not affect drug metabolism-related enzymes, and the facilitated carcinogenic response in the Tg-rasH2 mouse is not due to these enzymatic disorders.  (+info)

Further experiments on lipid peroxidation in transplanted and experimental hepatomas. (5/55)

The results of experiments on the subject of lipid peroxidation in hepatomas are described. It is now clear that lipid peroxidation is strongly decreased in most highly dedifferentiated hepatomas. It seems evident that the extent of the decline is strictly related to the degree of dedifferentiation. The model of diethylnitrosamine carcinogenesis, according to the method by Solt, Medline and Farber, has been now adopted to study the stages of carcinogenesis. It was shown that a net decline in lipid peroxidation occurs as early as at the stage of reversible nodules and progresses until the development of clear hepatomas. This change is practically simultaneous with a decline in the efficiency of the enzymes of the drug metabolizing system and in the content of cytochrome P450-Glutathione content and metabolism show also important changes. In fact, a dramatic increase in gamma-glutamyl-transpeptidase takes place very early during carcinogenesis, and is responsible for large decline in total glutathione during incubation of the homogenates. Glutathione peroxidase activity, on the contrary, is decreased, whereas glutathione reductase does not show significant changes. The supernatant of highly anaplastic tumors inhibits lipid peroxidation in normal liver homogenates, suggesting the presence of substances provided with antioxidant properties. These cannot be, however, related to a higher glutathione content. Supernatants from early nodules seem to be unable to block lipid peroxidation in normal liver homogenates. Preliminary experiments done to study the aldehyde pattern produced during lipid peroxidation, both in hepatomas and in nodules, confirm the presence of very poor lipid peroxidation and possibly of different peroxidation kinetics.  (+info)

Studies on the evaluation of the toxicity of various salts of lead, manganese, platinum, and palladium. (6/55)

Preliminary studies have been conducted on various parameters in order to assess the possible and relative toxicities of a number of metallic salts. Upon oral administration in lethal-dose experiments, two soluble Pt4+ salts were more toxic than the other salts tested. Following intraperiotneal injection in lethal-dose experiments, PbCl2 was less toxic than several of the soluble or partially soluble salts of Pt4+, Pd2+, and Mn2+. An intake of a total of approximately 250 mg of Pt4+ per rat in the drinking fluid over a 30-day interval did not affect the activities of aniline hydroxylase and aminopyrine demethylase in rat liver microsomes. In rats receiving soluble Pt4+ salts in the drinking fluid, the highest concentration of Pt was found in the kidney and an appreciiable concentration was found in the liver.  (+info)

Inhibition of human hepatic cytochrome P450s and steroidogenic CYP17 by nonylphenol. (7/55)

Effect of nonylphenol on aminopyrine N-demethylase activity, a typical drug-metabolizing enzyme activity, by ten kinds of human hepatic cytochrome P450s (CYP) and on progesterone 17alpha-hydroxylase activity by steroidogenic CYP17 was investigated. When determined at 2 mM substrate concentration, nonylphenol (1 mM) most efficiently inhibited aminopyrine N-demethylation by CYP2C9 and CYP2C19, by 61% and 59%, respectively, followed by CYP2D6, CYP1A2, CYP2C18 and CYP2C8 (46-51%), whereas inhibition of the activities by other CYPs was less than 27%. Additionally, nonylphenol competitively inhibited diclofenac 4'-hydroxylation by CYP2C9 and S-mephenytoin 4'-hydroxylation by CYP2C19 with Ki values of 5.3 and 37 microM, respectively. Furthermore, nonylphenol exhibited a competitive inhibition of progesterone 17alpha-hydroxylase activity by CYP17 with Ki value of 62 microM. These results suggest that nonylphenol inhibits human hepatic CYPs, especially CYP2C9 and CYP2C19, and steroidogenic CYP17 activities.  (+info)

Hepatic microsomal enzyme induction in rats fed varietal cauliflower leaves. (8/55)

Leaves from a standard, insect-susceptible cauliflower variety and an insect-resistant strain were formulated at either 10 or 25% into semipurified diets for male and female weanling rats. After 3 weeks, relative liver weights, microsomal protein, cytochrome P-450, and activities of hepatic microsomal aminopyrine N-demethylase, aniline hydroxylase, p-nitroanisole O-demethylase, and N-methylaniline N-demethylase were determined. Growth, feed intake, and feed efficiency of male rats were not affected by the inclusion of the dried cauliflower leaf in the diet. However, female rats exhibited a depressed feed intake and increased feed efficiency with cauliflower leaf supplemental diets. Relative liver weights increased with increasing percentage of cauliflower leaves in the diet. Hepatic microsomal enzyme response to cauliflower leaf supplementation of the diet was greater in males than in females. Only aniline hydroxylase activity remained unchanged by the test diets. Male rats showed significant increases in N- and O-demethylation with both the 10 and 25% cauliflower diets, and increased values for microsomal protein and cytochrome P-450 at the 25% supplemental level. Female rats did not show significant hepatic microsomal induction from cauliflower leaf consumption at the 10% level. However, cytochrome P-450 and the metabolism of aminopyrine and p-nitroanisole were enhanced by consumption of cauliflower leaves at 25% of their diet. None of the parameters tested in this study evidenced a difference between the two cauliflower cultivars fed to either sex.  (+info)

Aminopyrine is a type of medication known as a non-opioid analgesic, which is used to relieve pain and reduce fever. It is an antipyretic and analgesic drug that was widely used in the past, but its use has been limited or discontinued in many countries due to the risk of rare but serious side effects such as agranulocytosis (a severe decrease in white blood cells), which can make individuals more susceptible to infections.

Chemically, aminopyrine is an aromatic heterocyclic compound containing a pyridine ring substituted with an amino group and a phenyl group. It works by inhibiting the enzyme cyclooxygenase (COX), which is involved in the production of prostaglandins, chemicals that mediate pain and inflammation. By reducing prostaglandin levels, aminopyrine helps to alleviate pain and reduce fever.

It's important to note that due to its potential side effects, aminopyrine is not commonly used in modern medical practice, and other safer and more effective medications are available for pain relief and fever reduction.

Aminopyrine N-demethylase is an enzyme that plays a role in the metabolism of drugs and other xenobiotics. It is primarily found in the liver and is responsible for catalyzing the N-demethylation of aminopyrine, a compound with analgesic and anti-inflammatory properties.

The enzyme works by transferring a methyl group from the aminopyrine molecule to a cofactor called NADPH, resulting in the formation of formaldehyde and dimethylaniline as products. This reaction is an important step in the biotransformation of many drugs and other foreign substances, allowing them to be more easily excreted from the body.

Aminopyrine N-demethylase is classified as a cytochrome P450 enzyme, which is a group of heme-containing proteins that are involved in oxidative metabolism. The activity of this enzyme can be influenced by various factors, including genetic polymorphisms, age, sex, and exposure to certain drugs or chemicals.

In addition to its role in drug metabolism, aminopyrine N-demethylase has also been used as a marker of liver function and as a tool for studying the regulation of cytochrome P450 enzymes.

Sterol 14-demethylase is an enzyme that plays a crucial role in the biosynthesis of sterols, particularly ergosterol in fungi and cholesterol in animals. This enzyme is classified as a cytochrome P450 (CYP) enzyme and is located in the endoplasmic reticulum.

The function of sterol 14-demethylase is to remove methyl groups from the sterol molecule at the 14th position, which is a necessary step in the biosynthesis of ergosterol or cholesterol. Inhibition of this enzyme can disrupt the normal functioning of cell membranes and lead to various physiological changes, including impaired growth and development.

Sterol 14-demethylase inhibitors (SDIs) are a class of antifungal drugs that target this enzyme and are used to treat fungal infections. Examples of SDIs include fluconazole, itraconazole, and ketoconazole. These drugs work by binding to the heme group of the enzyme and inhibiting its activity, leading to the accumulation of toxic sterol intermediates and disruption of fungal cell membranes.

Histone demethylases are enzymes that remove methyl groups from histone proteins, which are the structural components around which DNA is wound in chromosomes. These enzymes play a crucial role in regulating gene expression by modifying the chromatin structure and influencing the accessibility of DNA to transcription factors and other regulatory proteins.

Histones can be methylated at various residues, including lysine and arginine residues, and different histone demethylases specifically target these modified residues. Histone demethylases are classified into two main categories based on their mechanisms of action:

1. Lysine-specific demethylases (LSDs): These enzymes belong to the flavin adenine dinucleotide (FAD)-dependent amine oxidase family and specifically remove methyl groups from lysine residues. They target mono- and di-methylated lysines but cannot act on tri-methylated lysines.
2. Jumonji C (JmjC) domain-containing histone demethylases: These enzymes utilize Fe(II) and α-ketoglutarate as cofactors to hydroxylate methyl groups on lysine residues, leading to their removal. JmjC domain-containing histone demethylases can target all three states of lysine methylation (mono-, di-, and tri-methylated).

Dysregulation of histone demethylases has been implicated in various human diseases, including cancer, neurological disorders, and cardiovascular diseases. Therefore, understanding the functions and regulation of these enzymes is essential for developing novel therapeutic strategies to target these conditions.

Jumonji domain-containing histone demethylases (JHDMs) are a family of enzymes that are responsible for removing methyl groups from specific residues on histone proteins. These enzymes play crucial roles in the regulation of gene expression by modifying the chromatin structure and influencing the accessibility of transcription factors to DNA.

JHDMs contain a conserved Jumonji C (JmjC) domain, which is responsible for their demethylase activity. They are classified into two main groups based on the type of methyl group they remove: lysine-specific demethylases (KDMs) and arginine-specific demethylases (RDMs).

KDMs can be further divided into several subfamilies, including KDM2/7, KDM3, KDM4, KDM5, and KDM6, based on their substrate specificity and the number of methyl groups they remove. For example, KDM4 enzymes specifically demethylate di- and tri-methylated lysine 9 and lysine 36 residues on histone H3, while KDM5 enzymes target mono-, di-, and tri-methylated lysine 4 residues on histone H3.

RDMs, on the other hand, are responsible for demethylating arginine residues on histones, including symmetrically or asymmetrically dimethylated arginine 2, 8, 17, and 26 residues on histone H3 and H4.

Dysregulation of JHDMs has been implicated in various human diseases, including cancer, neurological disorders, and cardiovascular diseases. Therefore, understanding the functions and regulation of JHDMs is essential for developing novel therapeutic strategies to treat these diseases.

Oxidoreductases are a class of enzymes that catalyze oxidation-reduction reactions, where a electron is transferred from one molecule to another. N-Demethylating oxidoreductases are a specific subclass of these enzymes that catalyze the removal of a methyl group (-CH3) from a nitrogen atom (-N) in a molecule, which is typically a xenobiotic compound (a foreign chemical substance found within an living organism). This process often involves the transfer of electrons and the formation of water as a byproduct.

The reaction catalyzed by N-demethylating oxidoreductases can be represented as follows:
R-N-CH3 + O2 + H2O → R-N-H + CH3OH + H2O2

where R represents the rest of the molecule. The removal of the methyl group is often an important step in the metabolism and detoxification of xenobiotic compounds, as it can make them more water soluble and facilitate their excretion from the body.

Aniline hydroxylase is an enzyme that is involved in the metabolism of aromatic compounds, including aniline and other related substances. The enzyme catalyzes the addition of a hydroxyl group (-OH) to the aromatic ring of these compounds, which helps to make them more water-soluble and facilitates their excretion from the body.

Aniline hydroxylase is found in various tissues throughout the body, including the liver, lung, and kidney. It is a member of the cytochrome P450 family of enzymes, which are known for their role in drug metabolism and other xenobiotic-metabolizing reactions.

It's important to note that exposure to aniline and its derivatives can be harmful and may cause various health effects, including damage to the liver and other organs. Therefore, it is essential to handle these substances with care and follow appropriate safety precautions.

Parietal cells, also known as oxyntic cells, are a type of cell found in the gastric glands of the stomach lining. They play a crucial role in digestion by releasing hydrochloric acid and intrinsic factor into the stomach lumen. Hydrochloric acid is essential for breaking down food particles and creating an acidic environment that kills most bacteria, while intrinsic factor is necessary for the absorption of vitamin B12 in the small intestine. Parietal cells are stimulated by histamine, acetylcholine, and gastrin to release their secretory products.

Microsomes, liver refers to a subcellular fraction of liver cells (hepatocytes) that are obtained during tissue homogenization and subsequent centrifugation. These microsomal fractions are rich in membranous structures known as the endoplasmic reticulum (ER), particularly the rough ER. They are involved in various important cellular processes, most notably the metabolism of xenobiotics (foreign substances) including drugs, toxins, and carcinogens.

The liver microsomes contain a variety of enzymes, such as cytochrome P450 monooxygenases, that are crucial for phase I drug metabolism. These enzymes help in the oxidation, reduction, or hydrolysis of xenobiotics, making them more water-soluble and facilitating their excretion from the body. Additionally, liver microsomes also host other enzymes involved in phase II conjugation reactions, where the metabolites from phase I are further modified by adding polar molecules like glucuronic acid, sulfate, or acetyl groups.

In summary, liver microsomes are a subcellular fraction of liver cells that play a significant role in the metabolism and detoxification of xenobiotics, contributing to the overall protection and maintenance of cellular homeostasis within the body.

Retinoblastoma-Binding Protein 2 (RBP2) is a protein that is encoded by the EZH2 gene in humans. It is a core component of the Polycomb Repressive Complex 2 (PRC2), which is a multi-subunit protein complex involved in the epigenetic regulation of gene expression through histone modification. Specifically, RBP2/EZH2 functions as a histone methyltransferase that trimethylates lysine 27 on histone H3 (H3K27me3), leading to transcriptional repression of target genes. Retinoblastoma-Binding Protein 2 was so named because it was initially identified as a protein that interacts with the retinoblastoma protein (pRb), a tumor suppressor that regulates cell cycle progression and differentiation. However, its role in the development of retinoblastoma or other cancers is not well understood.

The Cytochrome P-450 (CYP450) enzyme system is a group of enzymes found primarily in the liver, but also in other organs such as the intestines, lungs, and skin. These enzymes play a crucial role in the metabolism and biotransformation of various substances, including drugs, environmental toxins, and endogenous compounds like hormones and fatty acids.

The name "Cytochrome P-450" refers to the unique property of these enzymes to bind to carbon monoxide (CO) and form a complex that absorbs light at a wavelength of 450 nm, which can be detected spectrophotometrically.

The CYP450 enzyme system is involved in Phase I metabolism of xenobiotics, where it catalyzes oxidation reactions such as hydroxylation, dealkylation, and epoxidation. These reactions introduce functional groups into the substrate molecule, which can then undergo further modifications by other enzymes during Phase II metabolism.

There are several families and subfamilies of CYP450 enzymes, each with distinct substrate specificities and functions. Some of the most important CYP450 enzymes include:

1. CYP3A4: This is the most abundant CYP450 enzyme in the human liver and is involved in the metabolism of approximately 50% of all drugs. It also metabolizes various endogenous compounds like steroids, bile acids, and vitamin D.
2. CYP2D6: This enzyme is responsible for the metabolism of many psychotropic drugs, including antidepressants, antipsychotics, and beta-blockers. It also metabolizes some endogenous compounds like dopamine and serotonin.
3. CYP2C9: This enzyme plays a significant role in the metabolism of warfarin, phenytoin, and nonsteroidal anti-inflammatory drugs (NSAIDs).
4. CYP2C19: This enzyme is involved in the metabolism of proton pump inhibitors, antidepressants, and clopidogrel.
5. CYP2E1: This enzyme metabolizes various xenobiotics like alcohol, acetaminophen, and carbon tetrachloride, as well as some endogenous compounds like fatty acids and prostaglandins.

Genetic polymorphisms in CYP450 enzymes can significantly affect drug metabolism and response, leading to interindividual variability in drug efficacy and toxicity. Understanding the role of CYP450 enzymes in drug metabolism is crucial for optimizing pharmacotherapy and minimizing adverse effects.

Methylation, in the context of genetics and epigenetics, refers to the addition of a methyl group (CH3) to a molecule, usually to the nitrogenous base of DNA or to the side chain of amino acids in proteins. In DNA methylation, this process typically occurs at the 5-carbon position of cytosine residues that precede guanine residues (CpG sites) and is catalyzed by enzymes called DNA methyltransferases (DNMTs).

DNA methylation plays a crucial role in regulating gene expression, genomic imprinting, X-chromosome inactivation, and suppression of repetitive elements. Hypermethylation or hypomethylation of specific genes can lead to altered gene expression patterns, which have been associated with various human diseases, including cancer.

In summary, methylation is a fundamental epigenetic modification that influences genomic stability, gene regulation, and cellular function by introducing methyl groups to DNA or proteins.

Histones are highly alkaline proteins found in the chromatin of eukaryotic cells. They are rich in basic amino acid residues, such as arginine and lysine, which give them their positive charge. Histones play a crucial role in packaging DNA into a more compact structure within the nucleus by forming a complex with it called a nucleosome. Each nucleosome contains about 146 base pairs of DNA wrapped around an octamer of eight histone proteins (two each of H2A, H2B, H3, and H4). The N-terminal tails of these histones are subject to various post-translational modifications, such as methylation, acetylation, and phosphorylation, which can influence chromatin structure and gene expression. Histone variants also exist, which can contribute to the regulation of specific genes and other nuclear processes.

Gastric acid, also known as stomach acid, is a digestive fluid produced in the stomach. It's primarily composed of hydrochloric acid (HCl), potassium chloride (KCl), and sodium chloride (NaCl). The pH of gastric acid is typically between 1.5 and 3.5, making it a strong acid that helps to break down food by denaturing proteins and activating digestive enzymes.

The production of gastric acid is regulated by the enteric nervous system and several hormones. The primary function of gastric acid is to initiate protein digestion, activate pepsinogen into the active enzyme pepsin, and kill most ingested microorganisms. However, an excess or deficiency in gastric acid secretion can lead to various gastrointestinal disorders such as gastritis, ulcers, and gastroesophageal reflux disease (GERD).

Nitroanisole O-Demethylase is not a commonly used medical term, but it is related to the field of biochemistry and toxicology. It refers to an enzyme that catalyzes the removal of a methyl group (CH3) from a specific chemical compound called nitroanisole.

Nitroanisole is an organic compound consisting of a methoxy (O-CH3) group attached to the phenyl ring of a nitrobenzene molecule. The enzyme Nitroanisole O-Demethylase facilitates the biotransformation process by breaking down nitroanisole into other compounds, specifically into nitrophenol and formaldehyde.

This reaction is important in understanding how the body metabolizes and eliminates foreign substances like drugs or toxins. However, it is not a term typically used in clinical medicine for diagnosing or treating medical conditions.

Oxidoreductases, O-demethylating are enzymes that belong to the larger family of oxidoreductases. Specifically, they are involved in catalyzing the removal of methyl groups (-CH3) from various substrates through oxidation reactions. This process is known as O-demethylation.

These enzymes play a crucial role in the metabolism of xenobiotics (foreign substances) such as drugs, toxins, and carcinogens. They help convert these substances into more water-soluble forms, which can then be easily excreted from the body. O-demethylating oxidoreductases are often found in the liver, where they contribute to the detoxification of xenobiotics.

The reaction catalyzed by these enzymes involves the transfer of a hydrogen atom and the addition of an oxygen atom to the methyl group, resulting in the formation of formaldehyde (-CH2O) and a demethylated product. The cytochrome P450 family of enzymes is one example of O-demethylating oxidoreductases.

Antipyrine is a chemical compound that was commonly used as a fever reducer and pain reliever in the past. It is a type of phenylpyrazole antipyretic and analgesic. However, due to its potential for causing liver damage and other side effects, it has largely been replaced by other medications and is not widely used in modern medicine.

The medical definition of Antipyrine refers to this specific chemical compound with the formula C11H13N3O2, and not to any broader category of drugs or substances. It is a white crystalline powder that is soluble in alcohol, chloroform, and ether, but insoluble in water.

Antipyrine was first synthesized in 1883 and was widely used as a fever reducer and pain reliever until the mid-20th century. However, its use declined due to concerns about its safety profile, including the potential for liver damage, skin reactions, and other side effects.

Today, Antipyrine is still used in some medical applications, such as in the measurement of earwax conductivity as a way to assess hearing function. It may also be used in some topical creams and ointments for pain relief. However, its use as a systemic medication is generally not recommended due to its potential for causing harm.

Dipyrone is a medication that belongs to the class of drugs known as non-opioid analgesics. It is primarily used for its analgesic and antipyretic effects, which means it helps to relieve pain and reduce fever. Dipyrone works by inhibiting the production of prostaglandins, chemicals in the body that cause inflammation and sensitivity to pain.

Dipyrone is available in various forms, including tablets, suppositories, and intravenous solutions. It is commonly used to treat mild to moderate pain, such as headaches, menstrual cramps, and muscle aches. However, it is important to note that dipyrone has been banned in several countries, including the United States, due to its potential to cause agranulocytosis, a serious blood disorder that can lead to infection and other complications.

The medical definition of dipyrone is as follows:

Dipyrone (INN, BAN, USAN), also known as metamizole or novaminsulfon, is a non-opioid analgesic, antipyretic, and anti-inflammatory drug. It is used for the treatment of mild to moderate pain, fever, and inflammation. Dipyrone works by inhibiting the activity of cyclooxygenase (COX) enzymes, which are involved in the production of prostaglandins, chemicals that contribute to pain, fever, and inflammation. However, due to its potential to cause agranulocytosis, a serious blood disorder, dipyrone has been banned in several countries, including the United States.

Proadifen is not typically referred to as a medical term or definition in modern medicine. However, it is an old antihistamine drug that was used in the past for its properties as a monoamine oxidase inhibitor (MAOI). MAOIs were used primarily in the treatment of depression but have largely been replaced by newer classes of drugs due to their potential for serious side effects.

Here is a brief medical definition of Proadifen as an MAOI:

Proadifen (SKF-525A): An older, nonselective and irreversible monoamine oxidase inhibitor (MAOI) that was used in the past for its antidepressant effects. Its use has been largely discontinued due to the risk of serious adverse reactions, such as hypertensive crises, when combined with certain foods or medications containing tyramine.

Dealkylation is a chemical process that involves the removal of an alkyl group from a molecule. In the context of medical and biological sciences, dealkylation often refers to the breakdown of drugs or other xenobiotics (foreign substances) in the body by enzymes.

Dealkylation is one of the major metabolic pathways for the biotransformation of many drugs, including chemotherapeutic agents, opioids, and benzodiazepines. This process can result in the formation of more polar and water-soluble metabolites, which can then be excreted from the body through the urine or bile.

Dealkylation can occur via several mechanisms, including oxidative dealkylation catalyzed by cytochrome P450 enzymes, as well as non-oxidative dealkylation mediated by other enzymes. The specific dealkylation pathway depends on the structure of the substrate and the type of enzyme involved.

Phenobarbital is a barbiturate medication that is primarily used for the treatment of seizures and convulsions. It works by suppressing the abnormal electrical activity in the brain that leads to seizures. In addition to its anticonvulsant properties, phenobarbital also has sedative and hypnotic effects, which can be useful for treating anxiety, insomnia, and agitation.

Phenobarbital is available in various forms, including tablets, capsules, and elixirs, and it is typically taken orally. The medication works by binding to specific receptors in the brain called gamma-aminobutyric acid (GABA) receptors, which help to regulate nerve impulses in the brain. By increasing the activity of GABA, phenobarbital can help to reduce excessive neural activity and prevent seizures.

While phenobarbital is an effective medication for treating seizures and other conditions, it can also be habit-forming and carries a risk of dependence and addiction. Long-term use of the medication can lead to tolerance, meaning that higher doses may be needed to achieve the same effects. Abruptly stopping the medication can also lead to withdrawal symptoms, such as anxiety, restlessness, and seizures.

Like all medications, phenobarbital can have side effects, including dizziness, drowsiness, and impaired coordination. It can also interact with other medications, such as certain antidepressants and sedatives, so it is important to inform your healthcare provider of all medications you are taking before starting phenobarbital.

In summary, phenobarbital is a barbiturate medication used primarily for the treatment of seizures and convulsions. It works by binding to GABA receptors in the brain and increasing their activity, which helps to reduce excessive neural activity and prevent seizures. While phenobarbital can be effective, it carries a risk of dependence and addiction and can have side effects and drug interactions.

Hexobarbital is a medication that belongs to the class of drugs called barbiturates. It is primarily used as a short-acting sedative and hypnotic agent, which means it can help induce sleep and reduce anxiety. Hexobarbital works by depressing the central nervous system, slowing down brain activity and causing relaxation and drowsiness.

It's important to note that hexobarbital is not commonly used in modern medical practice due to the availability of safer and more effective alternatives. Additionally, barbiturates like hexobarbital have a high potential for abuse and dependence, and their use is associated with several risks, including respiratory depression, overdose, and death, particularly when taken in combination with other central nervous system depressants such as alcohol or opioids.

Peroxides, in a medical context, most commonly refer to chemical compounds that contain the peroxide ion (O2−2). Peroxides are characterized by the presence of an oxygen-oxygen single bond and can be found in various substances.

In dentistry, hydrogen peroxide (H2O2) is a widely used agent for teeth whitening or bleaching due to its oxidizing properties. It can help remove stains and discoloration on the tooth surface by breaking down into water and oxygen-free radicals, which react with the stain molecules, ultimately leading to their oxidation and elimination.

However, it is essential to note that high concentrations of hydrogen peroxide or prolonged exposure can cause tooth sensitivity, irritation to the oral soft tissues, and potential damage to the dental pulp. Therefore, professional supervision and appropriate concentration control are crucial when using peroxides for dental treatments.

Pyrazolones are a group of non-steroidal anti-inflammatory drugs (NSAIDs) that contain a pyrazole ring in their chemical structure. They have analgesic, antipyretic, and anti-inflammatory properties. Pyrazolones include drugs such as phenylbutazone, oxyphenbutazone, and aminopyrine. However, due to their potential for serious side effects, including agranulocytosis (a severe decrease in white blood cells), pyrazolones are rarely used in modern clinical practice.

Lanosterol is a steroid that is an intermediate in the biosynthetic pathway of cholesterol in animals and other eukaryotic organisms. It's a complex organic molecule with a structure based on four fused hydrocarbon rings, and it plays a crucial role in maintaining the integrity and function of cell membranes.

In the biosynthetic pathway, lanosterol is produced from squalene through a series of enzymatic reactions. Lanosterol then undergoes several additional steps, including the removal of three methyl groups and the reduction of two double bonds, to form cholesterol.

Abnormal levels or structure of lanosterol have been implicated in certain genetic disorders, such as lamellar ichthyosis type 3 and congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD) syndrome.

Secobarbital is a barbiturate medication that is primarily used for the treatment of short-term insomnia and as a preoperative sedative. It works by depressing the central nervous system, producing a calming effect and helping to induce sleep. Secobarbital has a rapid onset of action and a relatively short duration of effect.

It is available in various forms, including capsules and injectable solutions, and is typically prescribed for use on an as-needed basis rather than as a regular medication. Secobarbital can be habit-forming and carries a risk of dependence and withdrawal, so it should only be used under the close supervision of a healthcare provider.

It's important to note that Secobarbital is not commonly prescribed in modern medical practice due to its high potential for abuse and the availability of safer and more effective sleep aids.

NADPH-ferrihemoprotein reductase, also known as diaphorase or NO synthase reductase, is an enzyme that catalyzes the reduction of ferrihemoproteins using NADPH as a reducing cofactor. This reaction plays a crucial role in various biological processes such as the detoxification of certain compounds and the regulation of cellular signaling pathways.

The systematic name for this enzyme is NADPH:ferrihemoprotein oxidoreductase, and it belongs to the family of oxidoreductases that use NADH or NADPH as electron donors. The reaction catalyzed by this enzyme can be represented as follows:

NADPH + H+ + ferrihemoprotein ↔ NADP+ + ferrohemoprotein

In this reaction, the ferric (FeIII) form of hemoproteins is reduced to its ferrous (FeII) form by accepting electrons from NADPH. This enzyme is widely distributed in various tissues and organisms, including bacteria, fungi, plants, and animals. It has been identified as a component of several multi-enzyme complexes involved in different metabolic pathways, such as nitric oxide synthase (NOS) and cytochrome P450 reductase.

In summary, NADPH-ferrihemoprotein reductase is an essential enzyme that catalyzes the reduction of ferrihemoproteins using NADPH as a reducing agent, playing a critical role in various biological processes and metabolic pathways.

Glutethimide is a sedative-hypnotic drug that was previously used for the treatment of insomnia and anxiety disorders. It belongs to the class of drugs known as non-barbiturate hypnotics. Glutethimide works by depressing the central nervous system (CNS), producing a calming effect on the brain.

Due to its potential for abuse, addiction, and its narrow therapeutic index, glutethimide is no longer commonly used in clinical practice. It has been replaced by safer and more effective sleep aids with fewer side effects and lower potential for misuse.

It's important to note that the use of glutethimide should be under the strict supervision of a healthcare professional, and it should only be taken as prescribed. Misuse or overuse of this medication can lead to serious health consequences, including respiratory depression, coma, and even death.

The seminal vesicles are a pair of glands located in the male reproductive system, posterior to the urinary bladder and superior to the prostate gland. They are approximately 5 cm long and have a convoluted structure with many finger-like projections called infoldings. The primary function of seminal vesicles is to produce and secrete a significant portion of the seminal fluid, which makes up the bulk of semen along with spermatozoa from the testes and fluids from the prostate gland and bulbourethral glands.

The secretion of the seminal vesicles is rich in fructose, which serves as an energy source for sperm, as well as various proteins, enzymes, vitamins, and minerals that contribute to maintaining the optimal environment for sperm survival, nourishment, and transport. During sexual arousal and ejaculation, the smooth muscles in the walls of the seminal vesicles contract, forcing the stored secretion into the urethra, where it mixes with other fluids before being expelled from the body as semen.

Microsomes are subcellular membranous vesicles that are obtained as a byproduct during the preparation of cellular homogenates. They are not naturally occurring structures within the cell, but rather formed due to fragmentation of the endoplasmic reticulum (ER) during laboratory procedures. Microsomes are widely used in various research and scientific studies, particularly in the fields of biochemistry and pharmacology.

Microsomes are rich in enzymes, including the cytochrome P450 system, which is involved in the metabolism of drugs, toxins, and other xenobiotics. These enzymes play a crucial role in detoxifying foreign substances and eliminating them from the body. As such, microsomes serve as an essential tool for studying drug metabolism, toxicity, and interactions, allowing researchers to better understand and predict the effects of various compounds on living organisms.

Histone-Lysine N-Methyltransferase is a type of enzyme that transfers methyl groups to specific lysine residues on histone proteins. These histone proteins are the main protein components of chromatin, which is the complex of DNA and proteins that make up chromosomes.

Histone-Lysine N-Methyltransferases play a crucial role in the regulation of gene expression by modifying the structure of chromatin. The addition of methyl groups to histones can result in either the activation or repression of gene transcription, depending on the specific location and number of methyl groups added.

These enzymes are important targets for drug development, as their dysregulation has been implicated in various diseases, including cancer. Inhibitors of Histone-Lysine N-Methyltransferases have shown promise in preclinical studies for the treatment of certain types of cancer.

Mixed Function Oxygenases (MFOs) are a type of enzyme that catalyze the addition of one atom each from molecular oxygen (O2) to a substrate, while reducing the other oxygen atom to water. These enzymes play a crucial role in the metabolism of various endogenous and exogenous compounds, including drugs, carcinogens, and environmental pollutants.

MFOs are primarily located in the endoplasmic reticulum of cells and consist of two subunits: a flavoprotein component that contains FAD or FMN as a cofactor, and an iron-containing heme protein. The most well-known example of MFO is cytochrome P450, which is involved in the oxidation of xenobiotics and endogenous compounds such as steroids, fatty acids, and vitamins.

MFOs can catalyze a variety of reactions, including hydroxylation, epoxidation, dealkylation, and deamination, among others. These reactions often lead to the activation or detoxification of xenobiotics, making MFOs an important component of the body's defense system against foreign substances. However, in some cases, these reactions can also produce reactive intermediates that may cause toxicity or contribute to the development of diseases such as cancer.

Lysine is an essential amino acid, which means that it cannot be synthesized by the human body and must be obtained through the diet. Its chemical formula is (2S)-2,6-diaminohexanoic acid. Lysine is necessary for the growth and maintenance of tissues in the body, and it plays a crucial role in the production of enzymes, hormones, and antibodies. It is also essential for the absorption of calcium and the formation of collagen, which is an important component of bones and connective tissue. Foods that are good sources of lysine include meat, poultry, fish, eggs, and dairy products.

Gastric mucosa refers to the innermost lining of the stomach, which is in contact with the gastric lumen. It is a specialized mucous membrane that consists of epithelial cells, lamina propria, and a thin layer of smooth muscle. The surface epithelium is primarily made up of mucus-secreting cells (goblet cells) and parietal cells, which secrete hydrochloric acid and intrinsic factor, and chief cells, which produce pepsinogen.

The gastric mucosa has several important functions, including protection against self-digestion by the stomach's own digestive enzymes and hydrochloric acid. The mucus layer secreted by the epithelial cells forms a physical barrier that prevents the acidic contents of the stomach from damaging the underlying tissues. Additionally, the bicarbonate ions secreted by the surface epithelial cells help neutralize the acidity in the immediate vicinity of the mucosa.

The gastric mucosa is also responsible for the initial digestion of food through the action of hydrochloric acid and pepsin, an enzyme that breaks down proteins into smaller peptides. The intrinsic factor secreted by parietal cells plays a crucial role in the absorption of vitamin B12 in the small intestine.

The gastric mucosa is constantly exposed to potential damage from various factors, including acid, pepsin, and other digestive enzymes, as well as mechanical stress due to muscle contractions during digestion. To maintain its integrity, the gastric mucosa has a remarkable capacity for self-repair and regeneration. However, chronic exposure to noxious stimuli or certain medical conditions can lead to inflammation, erosions, ulcers, or even cancer of the gastric mucosa.

A breath test is a medical or forensic procedure used to analyze a sample of exhaled breath in order to detect and measure the presence of various substances, most commonly alcohol. The test is typically conducted using a device called a breathalyzer, which measures the amount of alcohol in the breath and converts it into a reading of blood alcohol concentration (BAC).

In addition to alcohol, breath tests can also be used to detect other substances such as drugs or volatile organic compounds (VOCs) that may indicate certain medical conditions. However, these types of breath tests are less common and may not be as reliable or accurate as other diagnostic tests.

Breath testing is commonly used by law enforcement officers to determine whether a driver is impaired by alcohol and to establish probable cause for arrest. It is also used in some healthcare settings to monitor patients who are being treated for alcohol abuse or dependence.

Epigenetics is the study of heritable changes in gene function that occur without a change in the underlying DNA sequence. These changes can be caused by various mechanisms such as DNA methylation, histone modification, and non-coding RNA molecules. Epigenetic changes can be influenced by various factors including age, environment, lifestyle, and disease state.

Genetic epigenesis specifically refers to the study of how genetic factors influence these epigenetic modifications. Genetic variations between individuals can lead to differences in epigenetic patterns, which in turn can contribute to phenotypic variation and susceptibility to diseases. For example, certain genetic variants may predispose an individual to develop cancer, and environmental factors such as smoking or exposure to chemicals can interact with these genetic variants to trigger epigenetic changes that promote tumor growth.

Overall, the field of genetic epigenesis aims to understand how genetic and environmental factors interact to regulate gene expression and contribute to disease susceptibility.

The liver is a large, solid organ located in the upper right portion of the abdomen, beneath the diaphragm and above the stomach. It plays a vital role in several bodily functions, including:

1. Metabolism: The liver helps to metabolize carbohydrates, fats, and proteins from the food we eat into energy and nutrients that our bodies can use.
2. Detoxification: The liver detoxifies harmful substances in the body by breaking them down into less toxic forms or excreting them through bile.
3. Synthesis: The liver synthesizes important proteins, such as albumin and clotting factors, that are necessary for proper bodily function.
4. Storage: The liver stores glucose, vitamins, and minerals that can be released when the body needs them.
5. Bile production: The liver produces bile, a digestive juice that helps to break down fats in the small intestine.
6. Immune function: The liver plays a role in the immune system by filtering out bacteria and other harmful substances from the blood.

Overall, the liver is an essential organ that plays a critical role in maintaining overall health and well-being.

Histamine is defined as a biogenic amine that is widely distributed throughout the body and is involved in various physiological functions. It is derived primarily from the amino acid histidine by the action of histidine decarboxylase. Histamine is stored in granules (along with heparin and proteases) within mast cells and basophils, and is released upon stimulation or degranulation of these cells.

Once released into the tissues and circulation, histamine exerts a wide range of pharmacological actions through its interaction with four types of G protein-coupled receptors (H1, H2, H3, and H4 receptors). Histamine's effects are diverse and include modulation of immune responses, contraction and relaxation of smooth muscle, increased vascular permeability, stimulation of gastric acid secretion, and regulation of neurotransmission.

Histamine is also a potent mediator of allergic reactions and inflammation, causing symptoms such as itching, sneezing, runny nose, and wheezing. Antihistamines are commonly used to block the actions of histamine at H1 receptors, providing relief from these symptoms.

"Inbred strains of rats" are genetically identical rodents that have been produced through many generations of brother-sister mating. This results in a high degree of homozygosity, where the genes at any particular locus in the genome are identical in all members of the strain.

Inbred strains of rats are widely used in biomedical research because they provide a consistent and reproducible genetic background for studying various biological phenomena, including the effects of drugs, environmental factors, and genetic mutations on health and disease. Additionally, inbred strains can be used to create genetically modified models of human diseases by introducing specific mutations into their genomes.

Some commonly used inbred strains of rats include the Wistar Kyoto (WKY), Sprague-Dawley (SD), and Fischer 344 (F344) rat strains. Each strain has its own unique genetic characteristics, making them suitable for different types of research.

Aniline compounds, also known as aromatic amines, are organic compounds that contain a benzene ring substituted with an amino group (-NH2). Aniline itself is the simplest and most common aniline compound, with the formula C6H5NH2.

Aniline compounds are important in the chemical industry and are used in the synthesis of a wide range of products, including dyes, pharmaceuticals, and rubber chemicals. They can be produced by reducing nitrobenzene or by directly substituting ammonia onto benzene in a process called amination.

It is important to note that aniline compounds are toxic and can cause serious health effects, including damage to the liver, kidneys, and central nervous system. They can also be absorbed through the skin and are known to have carcinogenic properties. Therefore, appropriate safety measures must be taken when handling aniline compounds.

Semicarbazides are organic compounds that contain the functional group -NH-CO-NH-NH2. They are derivatives of hydrazine and carbamic acid, with the general structure (CH3)NHCSNH2. Semicarbazides are widely used in the synthesis of various chemical compounds, including heterocyclic compounds, pharmaceuticals, and agrochemicals.

In a medical context, semicarbazides themselves do not have any therapeutic use. However, they can be used in the preparation of certain drugs or drug intermediates. For example, semicarbazones, which are derivatives of semicarbazides, can be used to synthesize some antituberculosis drugs.

It is worth noting that semicarbazides and their derivatives have been found to have mutagenic and carcinogenic properties in some studies. Therefore, they should be handled with care in laboratory settings, and exposure should be minimized to reduce potential health risks.

Vanillic Acid is not a medical term, but it is a chemical compound with the name 4-hydroxy-3-methoxybenzoic acid. It is a type of phenolic acid that occurs naturally in some foods and plants, including vanilla beans, pineapples, and certain types of mushrooms.

Vanillic Acid has been studied for its potential antioxidant, anti-inflammatory, and neuroprotective properties. However, it is not considered a medication or a medical treatment and does not have a specific medical definition.

F-box proteins are a family of proteins that are characterized by the presence of an F-box domain, which is a motif of about 40-50 amino acids. This domain is responsible for binding to Skp1, a component of the SCF (Skp1-Cul1-F-box protein) E3 ubiquitin ligase complex. The F-box proteins serve as the substrate recognition subunit of this complex and are involved in targeting specific proteins for ubiquitination and subsequent degradation by the 26S proteasome.

There are multiple types of F-box proteins, including FBXW (also known as β-TrCP), FBXL, and FBLX, each with different substrate specificities. These proteins play important roles in various cellular processes such as cell cycle regulation, signal transduction, and DNA damage response by controlling the stability of key regulatory proteins.

Abnormal regulation of F-box proteins has been implicated in several human diseases, including cancer, developmental disorders, and neurodegenerative diseases.

Benzphetamine is a sympathomimetic amine, which is a type of drug that stimulates the sympathetic nervous system. It is a central nervous system stimulant and an appetite suppressant. Benzphetamine is used as a short-term supplement to diet and exercise in the treatment of obesity.

The medical definition of benzphetamine is:

A CNS stimulant and anorectic, structurally related to amphetamines, but pharmacologically related to the phenylethylamines. It has a longer duration of action than other amphetamines because it is absorbed more slowly and is excreted more slowly. Benzphetamine is used as an appetite suppressant in the treatment of obesity.

It's important to note that benzphetamine, like other weight-loss medications, should be used in conjunction with a reduced-calorie diet and exercise. It also has a risk for abuse and dependence, so it is usually prescribed for short-term use only.

Methylcholanthrene is a polycyclic aromatic hydrocarbon that is used in research to induce skin tumors in mice. It is a potent carcinogen and mutagen, and exposure to it can increase the risk of cancer in humans. It is not typically found in medical treatments or therapies.

Cytochrome reductases are a group of enzymes that play a crucial role in the electron transport chain, a process that occurs in the mitochondria of cells and is responsible for generating energy in the form of ATP (adenosine triphosphate). Specifically, cytochrome reductases are responsible for transferring electrons from one component of the electron transport chain to another, specifically to cytochromes.

There are several types of cytochrome reductases, including NADH dehydrogenase (also known as Complex I), succinate dehydrogenase (also known as Complex II), and ubiquinone-cytochrome c reductase (also known as Complex III). These enzymes help to facilitate the flow of electrons through the electron transport chain, which is essential for the production of ATP and the maintenance of cellular homeostasis.

Defects in cytochrome reductases can lead to a variety of mitochondrial diseases, which can affect multiple organ systems and may be associated with symptoms such as muscle weakness, developmental delays, and cardiac dysfunction.

Oxidoreductases are a class of enzymes that catalyze oxidation-reduction reactions, which involve the transfer of electrons from one molecule (the reductant) to another (the oxidant). These enzymes play a crucial role in various biological processes, including energy production, metabolism, and detoxification.

The oxidoreductase-catalyzed reaction typically involves the donation of electrons from a reducing agent (donor) to an oxidizing agent (acceptor), often through the transfer of hydrogen atoms or hydride ions. The enzyme itself does not undergo any permanent chemical change during this process, but rather acts as a catalyst to lower the activation energy required for the reaction to occur.

Oxidoreductases are classified and named based on the type of electron donor or acceptor involved in the reaction. For example, oxidoreductases that act on the CH-OH group of donors are called dehydrogenases, while those that act on the aldehyde or ketone groups are called oxidases. Other examples include reductases, peroxidases, and catalases.

Understanding the function and regulation of oxidoreductases is important for understanding various physiological processes and developing therapeutic strategies for diseases associated with impaired redox homeostasis, such as cancer, neurodegenerative disorders, and cardiovascular disease.

Enzyme induction is a process by which the activity or expression of an enzyme is increased in response to some stimulus, such as a drug, hormone, or other environmental factor. This can occur through several mechanisms, including increasing the transcription of the enzyme's gene, stabilizing the mRNA that encodes the enzyme, or increasing the translation of the mRNA into protein.

In some cases, enzyme induction can be a beneficial process, such as when it helps the body to metabolize and clear drugs more quickly. However, in other cases, enzyme induction can have negative consequences, such as when it leads to the increased metabolism of important endogenous compounds or the activation of harmful procarcinogens.

Enzyme induction is an important concept in pharmacology and toxicology, as it can affect the efficacy and safety of drugs and other xenobiotics. It is also relevant to the study of drug interactions, as the induction of one enzyme by a drug can lead to altered metabolism and effects of another drug that is metabolized by the same enzyme.

"Azoles" is a class of antifungal medications that have a similar chemical structure, specifically a five-membered ring containing nitrogen and two carbon atoms (a "azole ring"). The most common azoles used in medicine include:

1. Imidazoles: These include drugs such as clotrimazole, miconazole, and ketoconazole. They are used to treat a variety of fungal infections, including vaginal yeast infections, thrush, and skin infections.
2. Triazoles: These include drugs such as fluconazole, itraconazole, and voriconazole. They are also used to treat fungal infections, but have a broader spectrum of activity than imidazoles and are often used for more serious or systemic infections.

Azoles work by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. This leads to increased permeability of the cell membrane, which ultimately results in fungal cell death.

While azoles are generally well-tolerated, they can cause side effects such as nausea, vomiting, and abdominal pain. In addition, some azoles can interact with other medications and affect liver function, so it's important to inform your healthcare provider of all medications you are taking before starting an azole regimen.

Tranylcypromine is a type of antidepressant known as a non-selective, irreversible monoamine oxidase inhibitor (MAOI). It works by blocking the action of monoamine oxidase, an enzyme that breaks down certain neurotransmitters (chemical messengers) in the brain such as serotonin, dopamine, and noradrenaline. This leads to an increase in the levels of these neurotransmitters in the brain, which can help improve mood and alleviate symptoms of depression.

Tranylcypromine is used primarily for the treatment of major depressive disorder that has not responded to other antidepressants. It is also used off-label for the treatment of anxiety disorders, panic attacks, and obsessive-compulsive disorder.

It's important to note that MAOIs like tranylcypromine have several dietary and medication restrictions due to their potential to cause serious or life-threatening reactions when combined with certain foods or medications. Therefore, careful monitoring by a healthcare professional is necessary while taking this medication.

Sulfonium compounds are organosulfur molecules that contain a central sulfur atom bonded to three alkyl or aryl groups and have the general formula (R-S-R'-R'')+X-, where R, R', and R'' are organic groups and X is an anion. These compounds are widely used in chemical synthesis as phase-transfer catalysts, alkylating agents, and in the production of detergents, pharmaceuticals, and agrochemicals. Sulfonium compounds can also be found in some natural sources, such as certain antibiotics and marine toxins.

Pernicious anemia is a specific type of vitamin B12 deficiency anemia that is caused by a lack of intrinsic factor, a protein made in the stomach that is needed to absorb vitamin B12. The absence of intrinsic factor leads to poor absorption of vitamin B12 from food and results in its deficiency.

Vitamin B12 is essential for the production of healthy red blood cells, which carry oxygen throughout the body. Without enough vitamin B12, the body cannot produce enough red blood cells, leading to anemia. Pernicious anemia typically develops slowly over several years and can cause symptoms such as fatigue, weakness, pale skin, shortness of breath, and a decreased appetite.

Pernicious anemia is an autoimmune disorder, which means that the body's immune system mistakenly attacks healthy cells in the stomach lining, leading to a loss of intrinsic factor production. It is more common in older adults, particularly those over 60 years old, and can also be associated with other autoimmune disorders such as type 1 diabetes, Hashimoto's thyroiditis, and Addison's disease.

Treatment for pernicious anemia typically involves vitamin B12 replacement therapy, either through oral supplements or injections of the vitamin. In some cases, dietary changes may also be recommended to ensure adequate intake of vitamin B12-rich foods such as meat, fish, poultry, and dairy products.

Lipid peroxides are chemical compounds that form when lipids (fats or fat-like substances) oxidize. This process, known as lipid peroxidation, involves the reaction of lipids with oxygen in a way that leads to the formation of hydroperoxides and various aldehydes, such as malondialdehyde.

Lipid peroxidation is a naturally occurring process that can also be accelerated by factors such as exposure to radiation, certain chemicals, or enzymatic reactions. It plays a role in many biological processes, including cell signaling and regulation of gene expression, but it can also contribute to the development of various diseases when it becomes excessive.

Examples of lipid peroxides include phospholipid hydroperoxides, cholesteryl ester hydroperoxides, and triglyceride hydroperoxides. These compounds are often used as markers of oxidative stress in biological systems and have been implicated in the pathogenesis of atherosclerosis, cancer, neurodegenerative diseases, and other conditions associated with oxidative damage.

Tsyrlov, I. B.; Gerasimov, K. E. (1991). "Aminopyrine-N-demethylase. I. Directed modification of substrates' structure as a way ...
... hexachlorobiphenyl found increased activation of ethoxyresorufin deethylase and aminopyrine demethylase. However, while also ...
... aminopyrine n-demethylase MeSH D08.811.682.662.582.338 - cytochrome p-450 cyp2e1 MeSH D08.811.682.662.582.353 - cytochrome p- ... nitroanisole o-demethylase MeSH D08.811.682.690.416 - dioxygenases MeSH D08.811.682.690.416.277 - catechol 1,2-dioxygenase MeSH ... ethylmorphine-n-demethylase MeSH D08.811.682.662.582.550 - sarcosine dehydrogenase MeSH D08.811.682.662.582.700 - sarcosine ...
Imaoka S, Inoue K, Funae Y (1988). "Aminopyrine metabolism by multiple forms of cytochrome P-450 from rat liver microsomes: ... Suhara K, Ohashi K, Takahashi K, Katagiri M (1988). "Aromatase and nonaromatizing 10-demethylase activity of adrenal cortex ... simultaneous quantitation of four aminopyrine metabolites by high-performance liquid chromatography". Arch. Biochem. Biophys. ...
Tsyrlov, I. B.; Gerasimov, K. E. (1991). "Aminopyrine-N-demethylase. I. Directed modification of substrates structure as a way ...
Aminopyrine N-demethylase activity was decreased in males at 1000 and 10 000 ppm. No effects were seen in either sex at lower ... Aminopyrine demethylase and aniline hydroxylase activity were both decreased at 253 mg/kg bw/day and above. The cytochrome P- ...
The effects on aminopyrine-demethylase and acetanilide-hydroxylase activity were evaluated. The extracts were examined by thin ... Isooctane did not inhibit aminopyrine-demethylase or acetanilide-hydroxylase activity. TLC spots corresponding to ...
... aminopyrine N-demethylase, aryl hydrocarbon hydroxylase, aniline hydroxylase,and NADPH-cytochrome c reductase in the rodent ...
Simultaneously, detoxification enzyme activities (aminopyrine N-demethylase, erythromycin N-demethylase and glutathione-S- ...
N Demethylase, Aminopyrine use Aminopyrine N-Demethylase N Demethylase, Ethylmorphine use Ethylmorphine-N-Demethylase ... N-Demethylase, Aminopyrine use Aminopyrine N-Demethylase N-Demethylase, Erythromycin use Cytochrome P-450 CYP3A ...
N Demethylase, Aminopyrine use Aminopyrine N-Demethylase N Demethylase, Ethylmorphine use Ethylmorphine-N-Demethylase ... N-Demethylase, Aminopyrine use Aminopyrine N-Demethylase N-Demethylase, Erythromycin use Cytochrome P-450 CYP3A ...
However, there was no change in activities of either hepatic microsomal aminopyrine demethylase or glucose-6-phosphatase. ... MeSH Terms: Alkenes/toxicity*; Aminopyrine N-Demethylase/metabolism; Analysis of Variance; Aniline Hydroxylase/metabolism; ...
... the activities of rat liver aniline hydroxylase and aminopyrine demethylase. The methanol fraction could inhibit neither the ... such as d6-aminopyrine, can be used to measure endogenous nitrosation levels in experimental animals. In contrast, for higher ...
... aminopyrine N-demethylase, and aniline hydroxylase activity.[11] Of interest, multiple dosing (50 mg/kg i.p.) for 5 days led to ... a clinical study examining the effect of 28 days of therapy with silymarin showed no effect on the metabolism of aminopyrine ...
Aminopyrine N-Demethylase Entry term(s). Aminopyrine N Demethylase Demethylase, Aminopyrine N N Demethylase, Aminopyrine N- ... Aminopyrine N-demethylase Entry term(s):. Aminopyrine N Demethylase. Demethylase, Aminopyrine N. N Demethylase, Aminopyrine. N- ... Aminopyrine N-Demethylase - Preferred Concept UI. M0000966. Preferred term. ...
Aminopyrine N-Demethylase Preferred Concept UI. M0000966. Registry Number. EC 1.5.3.-. Terms. Aminopyrine N-Demethylase ... Aminopyrine N Demethylase Term UI T001903. Date01/26/1978. LexicalTag NON. ThesaurusID UNK (19XX). ... Aminopyrine N Demethylase Registry Number. EC 1.5.3.-. Previous Indexing. Oxidoreductases, N-Demethylating. Public MeSH Note. ... Aminopyrine N-Demethylase. Tree Number(s). D08.811.682.662.582.276. Unique ID. D000633. RDF Unique Identifier. http://id.nlm. ...
Aminopyrine N-Demethylase Preferred Concept UI. M0000966. Registry Number. EC 1.5.3.-. Terms. Aminopyrine N-Demethylase ... Aminopyrine N Demethylase Term UI T001903. Date01/26/1978. LexicalTag NON. ThesaurusID UNK (19XX). ... Aminopyrine N Demethylase Registry Number. EC 1.5.3.-. Previous Indexing. Oxidoreductases, N-Demethylating. Public MeSH Note. ... Aminopyrine N-Demethylase. Tree Number(s). D08.811.682.662.582.276. Unique ID. D000633. RDF Unique Identifier. http://id.nlm. ...
N0000007861 Aminopterin N0000007862 Aminopyridines N0000167058 Aminopyrine N0000167882 Aminopyrine N-Demethylase N0000007864 ... Heterocyclic N0000182048 Sterol 14-Demethylase N0000167624 Sterol Esterase N0000168149 Sterol O-Acyltransferase N0000169989 ... N0000167937 Nitrite Reductases N0000007649 Nitrites N0000008159 Nitro Compounds N0000167942 Nitroanisole O-Demethylase ... JNK Mitogen-Activated Protein Kinases N0000168421 Josamycin N0000180249 Jumonji Domain-Containing Histone Demethylases ...
... a decrease in cytochrome P-450 system content and in the activities of NADPH-cytochrome C reductase and aminopyrine demethylase ... the O-demethylases. Acetobacterium dehalogenans harbours different inducible O-demethylases with various substrate spectra. Two ... For the C-termini of the methyltransferases I of the vanillate- and the veratrol-O-demethylases, a TIM barrel structure of the ... Functional coupling between vanillate-O-demethylase and formaldehyde detoxification pathway. Hibi, Makoto; Sonoki, Tomonori; ...
Aminopyrine N T001903N Demethylase, Aminopyrine T001904Aminopyrine N-Demethylase T001904N-Demethylase, Aminopyrine ... Ethylmorphine N T015389Ethylmorphine N Demethylase T015389N Demethylase, Ethylmorphine T015390Ethylmorphine-N-Demethylase ... T001899Dimethylaminophenazone T001900Dipyrine T001901Amidophenazon T001902Aminofenazone T001903Aminopyrine N Demethylase ...
Aminopyrine Aminopyrine N-Demethylase Aminoquinolines Aminorex Aminosalicylic Acid Aminosalicylic Acids Amiodarone Amish ... Lysine Demethylase AlkB Homolog 5, RNA Demethylase AlkB Homolog 8, tRNA Methyltransferase Alkenes Alkyl and Aryl Transferases ... 14-alpha Demethylase Inhibitors 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid 15-Oxoprostaglandin 13- ... Ethylmorphine-N-Demethylase Ethylnitrosourea Ethynodiol Diacetate Etidocaine Etidronic Acid Etilefrine Etimizol Etiocholanolone ...
  • However, there was no change in activities of either hepatic microsomal aminopyrine demethylase or glucose-6-phosphatase. (nih.gov)
  • A preclinical study in rats demonstrated that single doses of garlic oil (500 mg/kg intraperitoneally [i.p.]) resulted in a significant depression of hepatic CYP450, aminopyrine N-demethylase, and aniline hydroxylase activity. (medscape.com)
  • no significant changes were noted in liver aminopyrine - N - demethylase or aniline hydrolase activities. (cdc.gov)
  • No significant changes in P-450 content or in the following activities were noted: ethylmorphine- N - demethylase, lauric acid 1 1-hydroxylation, and lauric acid 12-hydroxylation. (cdc.gov)